414 related articles for article (PubMed ID: 31649968)
1. Neurosteroids as novel antidepressants and anxiolytics: GABA-A receptors and beyond.
Zorumski CF; Paul SM; Covey DF; Mennerick S
Neurobiol Stress; 2019 Nov; 11():100196. PubMed ID: 31649968
[TBL] [Abstract][Full Text] [Related]
2. Preclinical and clinical pharmacology of brexanolone (allopregnanolone) for postpartum depression: a landmark journey from concept to clinic in neurosteroid replacement therapy.
Reddy DS; Mbilinyi RH; Estes E
Psychopharmacology (Berl); 2023 Sep; 240(9):1841-1863. PubMed ID: 37566239
[TBL] [Abstract][Full Text] [Related]
3. Neurosteroid replacement therapy for catamenial epilepsy, postpartum depression and neuroendocrine disorders in women.
Reddy DS
J Neuroendocrinol; 2022 Feb; 34(2):e13028. PubMed ID: 34506047
[TBL] [Abstract][Full Text] [Related]
4. [GABAergic approach of postpartum depression: A translational review of literature].
Verbe J; Dubertret C; El-Hage W; Bonnet-Brilhault F; Duriez P
Encephale; 2020 Apr; 46(2):123-134. PubMed ID: 31767256
[TBL] [Abstract][Full Text] [Related]
5. Allopregnanolone Mediates Affective Switching Through Modulation of Oscillatory States in the Basolateral Amygdala.
Antonoudiou P; Colmers PLW; Walton NL; Weiss GL; Smith AC; Nguyen DP; Lewis M; Quirk MC; Barros L; Melon LC; Maguire JL
Biol Psychiatry; 2022 Feb; 91(3):283-293. PubMed ID: 34561029
[TBL] [Abstract][Full Text] [Related]
6. Realising the therapeutic potential of neuroactive steroid modulators of the GABA
Belelli D; Hogenkamp D; Gee KW; Lambert JJ
Neurobiol Stress; 2020 May; 12():100207. PubMed ID: 32435660
[TBL] [Abstract][Full Text] [Related]
7. Relating neurosteroid modulation of inhibitory neurotransmission to behaviour.
Belelli D; Phillips GD; Atack JR; Lambert JJ
J Neuroendocrinol; 2022 Feb; 34(2):e13045. PubMed ID: 34644812
[TBL] [Abstract][Full Text] [Related]
8. Allopregnanolone-based treatments for postpartum depression: Why/how do they work?
Walton N; Maguire J
Neurobiol Stress; 2019 Nov; 11():100198. PubMed ID: 31709278
[TBL] [Abstract][Full Text] [Related]
9. Zuranolone - synthetic neurosteroid in treatment of mental disorders: narrative review.
Marecki R; Kałuska J; Kolanek A; Hakało D; Waszkiewicz N
Front Psychiatry; 2023; 14():1298359. PubMed ID: 38116383
[TBL] [Abstract][Full Text] [Related]
10. Brexanolone, a neurosteroid antidepressant, vindicates the GABAergic deficit hypothesis of depression and may foster resilience.
Lüscher B; Möhler H
F1000Res; 2019; 8():. PubMed ID: 31275559
[TBL] [Abstract][Full Text] [Related]
11. Neuroinflammation and psychiatric disorders: Relevance of C1q, translocator protein (18 kDa) (TSPO), and neurosteroids.
Rupprecht R; Rupprecht C; Di Benedetto B; Rammes G
World J Biol Psychiatry; 2022; 23(4):257-263. PubMed ID: 34320915
[TBL] [Abstract][Full Text] [Related]
12. Relevance of endogenous 3alpha-reduced neurosteroids to depression and antidepressant action.
Uzunova V; Sampson L; Uzunov DP
Psychopharmacology (Berl); 2006 Jun; 186(3):351-61. PubMed ID: 16249906
[TBL] [Abstract][Full Text] [Related]
13. Impaired Endogenous Neurosteroid Signaling Contributes to Behavioral Deficits Associated With Chronic Stress.
Walton NL; Antonoudiou P; Barros L; Dargan T; DiLeo A; Evans-Strong A; Gabby J; Howard S; Paracha R; Sánchez EJ; Weiss GL; Kong D; Maguire JL
Biol Psychiatry; 2023 Aug; 94(3):249-261. PubMed ID: 36736870
[TBL] [Abstract][Full Text] [Related]
14. Development of neuroactive steroids for the treatment of postpartum depression.
Gunduz-Bruce H; Takahashi K; Huang MY
J Neuroendocrinol; 2022 Feb; 34(2):e13019. PubMed ID: 34462985
[TBL] [Abstract][Full Text] [Related]
15. Brexanolone, a GABA
Edinoff AN; Odisho AS; Lewis K; Kaskas A; Hunt G; Cornett EM; Kaye AD; Kaye A; Morgan J; Barrilleaux PS; Lewis D; Viswanath O; Urits I
Front Psychiatry; 2021; 12():699740. PubMed ID: 34594247
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine insights into neurosteroid therapy for postpartum depression.
Reddy DS
Trends Mol Med; 2023 Dec; 29(12):979-982. PubMed ID: 37541828
[TBL] [Abstract][Full Text] [Related]
17. Allopregnanolone: From molecular pathophysiology to therapeutics. A historical perspective.
Paul SM; Pinna G; Guidotti A
Neurobiol Stress; 2020 May; 12():100215. PubMed ID: 32435665
[TBL] [Abstract][Full Text] [Related]
18. Neurosteroid influence on affective tone.
Walton NL; Antonoudiou P; Maguire JL
Neurosci Biobehav Rev; 2023 Sep; 152():105327. PubMed ID: 37499891
[TBL] [Abstract][Full Text] [Related]
19. Neuroactive Steroids and GABAergic Involvement in the Neuroendocrine Dysfunction Associated With Major Depressive Disorder and Postpartum Depression.
Maguire J
Front Cell Neurosci; 2019; 13():83. PubMed ID: 30906252
[TBL] [Abstract][Full Text] [Related]
20. Neurosteroids and translocator protein 18 kDa (TSPO) in depression: implications for synaptic plasticity, cognition, and treatment options.
Rupprecht R; Pradhan AK; Kufner M; Brunner LM; Nothdurfter C; Wein S; Schwarzbach J; Puig X; Rupprecht C; Rammes G
Eur Arch Psychiatry Clin Neurosci; 2023 Oct; 273(7):1477-1487. PubMed ID: 36574032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
